StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research note released on Sunday morning. The firm issued a hold rating on the biopharmaceutical ...

On the morning of January 15, 2025, the Carabinieri of the Sorrento company executed a pre-trial detention order issued by the Preliminary Investigations Judge (GIP) of the Torre Annunziata Court.

This biotech company says its coronavirus antibody treatment blocked 100% of infections in lab tests Sorrento Therapeutics says it's made a major breakthrough in a temporary, preventative ...

The industry’s presence is significant in Sorrento Valley, as this laidback, welcoming community is conveniently close to UCSD and other universities, as well as numerous life sciences companies. By ...

Letters, precautionary measure for a 30-year-old, is seriously suspected of the crime of aggravated robbery. The Carabinieri ...

Sorrento Therapeutics, Inc., a clinical and commercial stage biopharmaceutical company, develops a portfolio of next-generation treatments for three therapeutic areas: cancer, infectious disease ...